Although BCL2 has elevated expression levels in many cancers and is an anticancer target, overexpression of BCL2 alone in cells does not impart tumorigenic potential but rather can have prosurvival benefits (Lu et al. 1995; Kirkin et al. 2004; Czabotar et al. 2014). This evidence concerns the gene BCL2 and cancer.